Trial intelligence / Profile preview

Cyclobenzaprine vs Pelvic Floor Massage Wand for High Tone Pelvic Floor Dysfunction

NCT07404397Phase 3Recruiting

Sponsor
University of Michigan
Start
Feb 2026
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of cyclobenzaprine in High-tone pelvic floor dysfunction (HTPFD), sponsored by University of Michigan. Started Feb 2026; status: recruiting.

02

Drugs

cyclobenzaprine
03

Conditions

High-tone pelvic floor dysfunction (HTPFD)

Beyond the preview

Go deeper on NCT07404397.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07404397.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call